Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
4.3 Targeting CSCs through coordinated pathway disruption SFN demonstrates remarkable efficacy against CSCs through its ability to simultaneously disrupt multiple signaling pathways that maintain stemness and self-renewal capacity
PNA mice may provide the basis for the differential efficiency of GLP1/E in these two PCOS models
This addresses a long-standing clinical concern that adjunctive GLP-1 therapy might lead to dangerous insulin-dose imbalances
Institutional logos are displayed at checkout without actual endorsement
US$ 23.40
US$ 24.62
US$ 26.98
:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)
US$ 29.20
